350 related articles for article (PubMed ID: 30760655)
1. Sufficient and Persistent Blood Pressure Reduction in the Final Long-Term Results From SYMPLICITY HTN-Japan - Safety and Efficacy of Renal Denervation at 3 Years.
Kario K; Yamamoto E; Tomita H; Okura T; Saito S; Ueno T; Yasuhara D; Shimada K;
Circ J; 2019 Feb; 83(3):622-629. PubMed ID: 30760655
[TBL] [Abstract][Full Text] [Related]
2. SYMPLICITY HTN-Japan - First Randomized Controlled Trial of Catheter-Based Renal Denervation in Asian Patients - .
Kario K; Ogawa H; Okumura K; Okura T; Saito S; Ueno T; Haskin R; Negoita M; Shimada K;
Circ J; 2015; 79(6):1222-9. PubMed ID: 25912693
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
[TBL] [Abstract][Full Text] [Related]
4. Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study.
Rosa J; Widimský P; Waldauf P; Zelinka T; Petrák O; Táborský M; Branny M; Toušek P; Čurila K; Lambert L; Bednář F; Holaj R; Štrauch B; Václavík J; Kociánová E; Nykl I; Jiravský O; Rappová G; Indra T; Krátká Z; Widimský J
J Hypertens; 2017 May; 35(5):1093-1099. PubMed ID: 28118281
[TBL] [Abstract][Full Text] [Related]
5. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.
Kandzari DE; Bhatt DL; Brar S; Devireddy CM; Esler M; Fahy M; Flack JM; Katzen BT; Lea J; Lee DP; Leon MB; Ma A; Massaro J; Mauri L; Oparil S; O'Neill WW; Patel MR; Rocha-Singh K; Sobotka PA; Svetkey L; Townsend RR; Bakris GL
Eur Heart J; 2015 Jan; 36(4):219-27. PubMed ID: 25400162
[TBL] [Abstract][Full Text] [Related]
6. Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial.
Kario K; Mahfoud F; Kandzari DE; Townsend RR; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Brar S; Hettrick DA; Fahy M; Böhm M
Hypertens Res; 2023 Jan; 46(1):280-288. PubMed ID: 36241705
[TBL] [Abstract][Full Text] [Related]
7. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan.
Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL
Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819
[TBL] [Abstract][Full Text] [Related]
8. Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension.
Böhm M; Tsioufis K; Kandzari DE; Kario K; Weber MA; Schmieder RE; Townsend RR; Kulenthiran S; Ukena C; Pocock S; Ewen S; Weil J; Fahy M; Mahfoud F
J Am Coll Cardiol; 2021 Sep; 78(10):1028-1038. PubMed ID: 34474735
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
Oliveras A; Armario P; Clarà A; Sans-Atxer L; Vázquez S; Pascual J; De la Sierra A
J Hypertens; 2016 Sep; 34(9):1863-71. PubMed ID: 27327441
[TBL] [Abstract][Full Text] [Related]
10. 12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.
Bakris GL; Townsend RR; Flack JM; Brar S; Cohen SA; D'Agostino R; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
J Am Coll Cardiol; 2015 Apr; 65(13):1314-1321. PubMed ID: 25835443
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.
Wang J; Yin Y; Lu C; Lu Z; Hu J; Wang Y; Ge J; Jiang H; Yao C; Yan X; Ma W; Qi X; Dang Y; Chen S; Zhu J; Wang D; Ding C; Wang W; Liu J; Wang Y; Li H; Pan Z; Cui K; Li C; Liang X; Chen W; Sobotka PA; Zhang J; Esler M; Sun N; Chen M; Huo Y
EClinicalMedicine; 2024 Jun; 72():102626. PubMed ID: 38756107
[TBL] [Abstract][Full Text] [Related]
12. High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3.
Waksman R; Bakris GL; Steinvil A; Garcia-Garcia H; Brown AL; DiFilippo W; Scott T; Singh J; DeBruin V; Jones D; Jolivette D; Bhatt DL
Am Heart J; 2017 Oct; 192():76-84. PubMed ID: 28938966
[TBL] [Abstract][Full Text] [Related]
13. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
Townsend RR; Mahfoud F; Kandzari DE; Kario K; Pocock S; Weber MA; Ewen S; Tsioufis K; Tousoulis D; Sharp ASP; Watkinson AF; Schmieder RE; Schmid A; Choi JW; East C; Walton A; Hopper I; Cohen DL; Wilensky R; Lee DP; Ma A; Devireddy CM; Lea JP; Lurz PC; Fengler K; Davies J; Chapman N; Cohen SA; DeBruin V; Fahy M; Jones DE; Rothman M; Böhm M;
Lancet; 2017 Nov; 390(10108):2160-2170. PubMed ID: 28859944
[TBL] [Abstract][Full Text] [Related]
14. Renal denervation in moderate treatment-resistant hypertension.
Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.
Kandzari DE; Townsend RR; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; Konstantinidis D; Choi J; East C; Lauder L; Cohen DL; Kobayashi T; Schmid A; Lee DP; Ma A; Weil J; Agdirlioglu T; Schlaich MP; Shetty S; Devireddy CM; Lea J; Aoki J; Sharp ASP; Anderson R; Fahy M; DeBruin V; Brar S; Böhm M;
J Am Coll Cardiol; 2023 Nov; 82(19):1809-1823. PubMed ID: 37914510
[TBL] [Abstract][Full Text] [Related]
16. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
Fadl Elmula FE; Jin Y; Yang WY; Thijs L; Lu YC; Larstorp AC; Persu A; Sapoval M; Rosa J; Widimský P; Jacobs L; Renkin J; Petrák O; Chatellier G; Shimada K; Widimský J; Kario K; Azizi M; Kjeldsen SE; Staessen JA;
Blood Press; 2015; 24(5):263-74. PubMed ID: 26194721
[TBL] [Abstract][Full Text] [Related]
18. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis.
Scalise F; Sole A; Singh G; Sorropago A; Sorropago G; Ballabeni C; Maccario M; Vettoretti S; Grassi G; Mancia G
J Hypertens; 2020 May; 38(5):936-942. PubMed ID: 31990900
[TBL] [Abstract][Full Text] [Related]
19. Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.
Esler MD; Böhm M; Sievert H; Rump CL; Schmieder RE; Krum H; Mahfoud F; Schlaich MP
Eur Heart J; 2014 Jul; 35(26):1752-9. PubMed ID: 24898552
[TBL] [Abstract][Full Text] [Related]
20. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry.
Mahfoud F; Böhm M; Schmieder R; Narkiewicz K; Ewen S; Ruilope L; Schlaich M; Williams B; Fahy M; Mancia G
Eur Heart J; 2019 Nov; 40(42):3474-3482. PubMed ID: 30907413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
